Paul M. Keller

Overview

Best Publications

• A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

  M. N. Oxman;M. N. Oxman;M. J. Levin;G. R. Johnson;K. E. Schmader

  3032
  Citations

• Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

  John W. Shiver;Tong-Ming Fu;Ling Chen;Danilo R. Casimiro

  1521
  Citations

• Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine.

  J A Fyfe;P M Keller;P A Furman;R L Miller

  806
  Citations

• The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes

  Joseph G. Joyce;Jwu-Sheng Tung;Craig T. Przysiecki;James C. Cook

  617
  Citations

• Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

  Jiang Fan;Xiaoping Liang;Melanie S Horton;Helen C Perry

  445
  Citations

• Decline in Varicella-Zoster Virus (VZV)–Specific Cell-Mediated Immunity with Increasing Age and Boosting with a High-Dose VZV Vaccine

  Myron J. Levin;Jeffrey G. Smith;Robin M. Kaufhold;Debra Barber

  422
  Citations

• Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody.

  Anthony J. Conley;Joseph A. Kessler;Lynn J. Boots;Jwu-Sheng Tung

  336
  Citations

• Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality.

  Dennis Lee;Scott A. Long;Jerry L. Adams;George Chan

  323
  Citations

• Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy

  K. E. Schmader;M. N. Oxman;M. J. Levin;G. Johnson

  291
  Citations

• Potent and selective nonpeptide inhibitors of caspases 3 and 7

  Lee D;Long Sa;Murray Jh;Adams Jl

  242
  Citations

• Discovery of a Novel and Potent Class of FabI-Directed Antibacterial Agents

  David J. Payne;William H. Miller;Valerie Berry;John Brosky

  217
  Citations

• ENZYMATIC PHOSPHORYLATION OF ACYCLIC NUCLEOSIDE ANALOGS AND CORRELATIONS WITH ANTIHERPETIC ACTIVITIES

  Paul M. Keller;James A. Fyfe;Lilia Beauchamp;Carol M. Lubbers

  211
  Citations

• Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK.

  Mark A. Seefeld;William H. Miller;Kenneth A. Newlander;Walter J. Burgess

  209
  Citations

• Identification and structure of the gene encoding gpII, a major glycoprotein of varicella-zoster virus.

  Paul Malcolm Keller;Andrew J. Davison;Robert S. Lowe;Carl D. Bennett

  196
  Citations

• Solution State Characterization of Amyloid β-Derived Diffusible Ligands

  Robert W. Hepler;Karen M. Grimm;Deborah D. Nahas;Robert Breese

  187
  Citations

• Enhancement of α-Helicity in the HIV-1 Inhibitory Peptide DP178 Leads to an Increased Affinity for Human Monoclonal Antibody 2F5 but Does Not Elicit Neutralizing Responses in Vitro: IMPLICATIONS FOR VACCINE DESIGN

  Joseph G. Joyce;William M. Hurni;Michael J. Bogusky;Victor M. Garsky

  180
  Citations

• Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae.

  J C Cook;J G Joyce;H A George;L D Schultz

  159
  Citations

• New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products.

  A J Davison;C M Edson;R W Ellis;B Forghani

  155
  Citations

• Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI).

  William H. Miller;Mark A. Seefeld;Kenneth A. Newlander;Irene N. Uzinskas

  153
  Citations

• Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes.

  P M Keller;B J Neff;R W Ellis

  137
  Citations